Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL15917374

CC(C)NCc1ccccc1.N

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.63
POLB P06746 1/20 0.53
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
HRH1 P35367 1/20 0.47
IDO1 P14902 2/20 0.46
THRB P10828 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CASR P41180 1/20 0.46
CCR5 P51681 1/20 0.45
LTA4H P09960 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
SLC18A2 Q05940 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL143708 0.98 SIGMAR1 (0.65) SIGMAR1POLBKDM4ECYP3A4MAPT
SCHEMBL22899588 0.98 SIGMAR1 (0.65) SIGMAR1POLBKDM4ECYP3A4MAPT
Hydrochloric Acid SCHEMBL1331235 0.95 SIGMAR1 (0.63) SIGMAR1POLBKDM4ECYP3A4MAPT
Bromide SCHEMBL1331742 0.95 SIGMAR1 (0.63) SIGMAR1POLBKDM4ECYP3A4MAPT
Methyl Alcohol SCHEMBL29261100 0.93 SIGMAR1 (0.61) SIGMAR1POLBKDM4ECYP3A4MAPT
Alcohol SCHEMBL9136417 0.89 SIGMAR1 (0.57) SIGMAR1POLBKDM4ECYP3A4MAPT
Hydrochloric Acid SCHEMBL3332713 0.87 SIGMAR1 (0.55) SIGMAR1POLBKDM4ECYP3A4MAPT
Toluene SCHEMBL27514860 0.87 SMN1; SMN2 (0.61) SIGMAR1POLBKDM4ECYP3A4MAPT
Putrescine SCHEMBL8006412 0.86 SIGMAR1 (0.53) SIGMAR1POLBKDM4ECYP3A4MAPT
SCHEMBL22462469 0.86 SIGMAR1 (0.53) SIGMAR1POLBKDM4ECYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102702007-A Synthesis of 5-methoxyl-2-methylene-Nmethylformamide indene compounds SHENGSHI TAIKE BIOMEDICAL TECHNOLOGY SUZHOU CO LTD 2012-10-03 CN claimed
US-9051305-B2 Compositions and methods useful for treating diseases EUTROPICS PHARMACEUTICALS, INC. (US) 2015-06-09 US disclosed
US-20140221387-A1 COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES EUTROPICS PHARMACEUTICALS, INC. (US) 2014-08-07 US disclosed
CN-102702007-A Synthesis of 5-methoxyl-2-methylene-Nmethylformamide indene compounds SHENGSHI TAIKE BIOMEDICAL TECHNOLOGY SUZHOU CO LTD 2012-10-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221387-A1 COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES BCL3, MCL1, BCL6 SIGMAR1 4714/4885POLB 1677/4885KDM4E 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.